290 related articles for article (PubMed ID: 33559307)
61. A good preoperative immune prognostic index is precits a better prognosis for locally advanced rectal cancer patients with ypTNM stage II who underwent radical resection after neoadjuvant chemoradiotherapy.
Li S; Wang Y; Cai H; Pan Z; Guan G
Int J Colorectal Dis; 2023 Jul; 38(1):184. PubMed ID: 37395868
[TBL] [Abstract][Full Text] [Related]
62. Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective study.
Li QW; Zheng RL; Ling YH; Wang QX; Xiao WW; Zeng ZF; Fan W; Li LR; Gao YH
Abdom Radiol (NY); 2016 Aug; 41(8):1448-55. PubMed ID: 27116012
[TBL] [Abstract][Full Text] [Related]
63. One-level step section histological analysis is insufficient to confirm complete pathological response after neoadjuvant chemoradiation for rectal cancer.
Pereira MA; Dias AR; Faraj SF; Nahas CSR; Imperiale AR; Marques CFS; Cotti GC; Azevedo BC; Nahas SC; de Mello ES; Ribeiro U
Tech Coloproctol; 2017 Sep; 21(9):745-754. PubMed ID: 28819868
[TBL] [Abstract][Full Text] [Related]
64. [Risk factors related to lymph node metastases after neoadjuvant therapy for locally advanced rectal cancer].
Zeng ZF; Ding PR; Pan ZZ; Lin JZ; Li LR; Lu ZH; Wu XJ; Kong LH; Zhou ZG; Wan DS
Ai Zheng; 2009 Sep; 28(9):923-7. PubMed ID: 19728908
[TBL] [Abstract][Full Text] [Related]
65. Oncologic outcome after preoperative chemoradiotherapy in patients with pathologic T0 (ypT0) rectal cancer.
Jang TY; Yu CS; Yoon YS; Lim SB; Hong SM; Kim TW; Kim JH; Kim JC
Dis Colon Rectum; 2012 Oct; 55(10):1024-31. PubMed ID: 22965400
[TBL] [Abstract][Full Text] [Related]
66. Tumor Budding as a Prognostic Marker in Rectal Cancer Patients on Propensity Score Analysis.
Shin JK; Park YA; Huh JW; Yun SH; Kim HC; Lee WY; Kim SH; Ha SY; Cho YB
Ann Surg Oncol; 2021 Dec; 28(13):8813-8822. PubMed ID: 34232421
[TBL] [Abstract][Full Text] [Related]
67. Impact of glucocorticoids on the efficacy of neoadjuvant chemoradiotherapy and survival of patients with locally advanced rectal cancer: a retrospective study.
Huang X; Zheng Z; Zeng B; Xiao H; Zheng H; Lin Z; Song J; Li A; Chi P; Yang Y; Xu B; Zheng R
BMC Cancer; 2023 Mar; 23(1):238. PubMed ID: 36918865
[TBL] [Abstract][Full Text] [Related]
68. Prognostic significance of the distribution of lymph node metastasis in rectal cancer after neoadjuvant chemoradiation.
Lee SY; Kim CH; Kim YJ; Kim HR
J Surg Oncol; 2018 Mar; 117(3):514-522. PubMed ID: 29094377
[TBL] [Abstract][Full Text] [Related]
69. Tolerability, Safety, and Outcomes of Neoadjuvant Chemoradiotherapy With Capecitabine for Patients Aged ≥ 70 Years With Locally Advanced Rectal Cancer.
Jacobs L; van der Vlies E; Ten Bokkel Huinink D; Bloemendal H; Intven M; Smits AB; Weusten BLAM; Siersema PD; van Lelyveld N; Los M
Clin Colorectal Cancer; 2018 Sep; 17(3):179-186. PubMed ID: 29661620
[TBL] [Abstract][Full Text] [Related]
70. [Postoperative pathological staging correlates the prognosis of rectal cancer after neoadjuvant chemoradiotherapy].
Xiao Y; Lu J; Xiong G; Wu B; Lin G; Zhao L; Liang Z; Zhong G; Hu K; Pan W; Qiu H
Zhonghua Wai Ke Za Zhi; 2014 Feb; 52(2):99-104. PubMed ID: 24809516
[TBL] [Abstract][Full Text] [Related]
71. Worse prognosis in young patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy: A comparative study.
Zhang Y; Wang Y; Liu X; Chen B; Zhuang J; Li S; Yang Y; Su Y; Guan G
Medicine (Baltimore); 2020 Aug; 99(35):e21304. PubMed ID: 32871861
[TBL] [Abstract][Full Text] [Related]
72. Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy.
Lu S; Liu Z; Zhou X; Wang B; Li F; Ma Y; Wang W; Ma J; Wang Y; Wang H; Fu W
Cancer Manag Res; 2020; 12():8555-8568. PubMed ID: 32982448
[TBL] [Abstract][Full Text] [Related]
73. Predictors and histological effects of preoperative chemoradiotherapy for rectal cancer and control of lateral lymph node metastasis.
Miyakita H; Chan LF; Okada K; Kayano H; Mori M; Sadahiro S; Yamamoto S
BMC Gastroenterol; 2022 Jul; 22(1):334. PubMed ID: 35804299
[TBL] [Abstract][Full Text] [Related]
74. Defining and predicting early recurrence in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Zheng Z; Wang X; Huang Y; Lu X; Huang Z; Chi P
Eur J Surg Oncol; 2020 Nov; 46(11):2057-2063. PubMed ID: 32782202
[TBL] [Abstract][Full Text] [Related]
75. Prognostic Value of the Distribution of Lymph Node Metastasis in Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy.
Chen B; Liu X; Zhang Y; Zhuang J; Peng Y; Wang Y; Wu Y; Li S; Yang Y; Guan G
Front Surg; 2021; 8():749575. PubMed ID: 34869558
[No Abstract] [Full Text] [Related]
76. Impact of adjuvant chemotherapy on patients with ypT0-2 ypN0 rectal cancer after neoadjuvant chemoradiation: a cohort study from a tertiary referral hospital.
Galata C; Merx K; Mai S; Gaiser T; Wenz F; Post S; Kienle P; Hofheinz RD; Horisberger K
World J Surg Oncol; 2018 Aug; 16(1):156. PubMed ID: 30071852
[TBL] [Abstract][Full Text] [Related]
77. Prognostic Impact of the Neoadjuvant Rectal Score as Compared With the Tumor Regression Grade and Yield Pathologic TNM Stage in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy.
Baek JH; Baek DW; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Kim JG
In Vivo; 2020; 34(4):1993-1999. PubMed ID: 32606172
[TBL] [Abstract][Full Text] [Related]
78. Prognostic Value of the Circumferential Resection Margin in Esophageal Cancer Patients After Neoadjuvant Chemoradiotherapy.
Hulshoff JB; Faiz Z; Karrenbeld A; Kats-Ugurlu G; Burgerhof JG; Smit JK; Plukker JT
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1301-9. PubMed ID: 26314875
[TBL] [Abstract][Full Text] [Related]
79. Prognostic significance of tumor regression in lymph nodes after neoadjuvant therapy for rectal carcinoma.
Fernández-Aceñero MJ; Granja M; Sastre J; García-Paredes B; Estrada L
Virchows Arch; 2016 Apr; 468(4):425-30. PubMed ID: 26754675
[TBL] [Abstract][Full Text] [Related]
80. Endorectal ultrasound does not reliably identify patients with uT3 rectal cancer who can avoid neoadjuvant chemoradiotherapy.
Shapiro R; Ahmed Ali U; Lavery IC; Kiran RP
Int J Colorectal Dis; 2013 Jul; 28(7):993-1000. PubMed ID: 23377857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
